DOCSLIB.ORG

GG&C Top Level Suppliers

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
GG&C Top Level Suppliers GG&C Top Level Suppliers Supplier Long Name Supplier Code 3M HEALTHCARE LTD HEA01 AAH BULK PACKS 372 DIST AAH PHARMACEUTICALS (EDINBURGH) AAH02 AAH PHARMACEUTICALS LTD AAH01 AAH PHARMACEUTICALS LTD AAH01 AAH PHARMACEUTICALS LTD AAHCD AAH PHARMACEUTICALS LTD AAHRO ABBOTT DIAGNOSTICS DIVISION ABB02 ABBOTT LABORATORIES ABB01 ABBOTT LABORATORIES ABB01 ACTAVIS UK LTD ACT36 ADAMS HEALTHCARE ADA01 ADELPHI MANUFACTURING CO LTD ADE04 ADVANCIS ADV16 AGEPHA PHARMACEUTICALS AGE40 AGMA PLC AGM01 AIR LIQUIDE LTD LIN01 AIR PRODUCTS LIMITED AIR01 ALAN PHARMACEUTICALS ALA04 ALARIS MEDICAL SYSTEMS ALA01 ALCON LABORATORIES (UK) LTD ALC01 ALCON LABORATORIES (UK) LTD ALC01 Alexion Pharma UK LTD ALE25 ALK ABELLO UK LIMITED ALK01 ALLERAYDE UK LTD ALL63 ALLERGAN LIMITED ALL04 ALLERGAN LIMITED ALL04 ALLERGAN PHARMACEUTICALS IRELAND ALLER ALLERGAN PHARMACEUTICALS IRELAND ALLER ALLERGY THERAPEUTICS LTD ALL19 ALLIANCE HEALTHCARE LTD ALLCD ALLIANCE HEALTHCARE LTD ALLRO ALLIANCE HEALTHCARE LTD UNI04 ALLIANCE HEALTHCARE LTD UNI04 ALLIANCE PHARMACEUTICALS ALL15 ALLIANCE PHARMACEUTICALS ALL15 ALLIANCE PHARMACY ALL46 ALLIBERT HANDLING ALLIB ALPHA LABORATORIES LTD ALP01 A.MENARINI DIAGNOSTICS MEN02 A. MENARINI PHARMA UK SRL MEN01 A. MENARINI PHARMA UK SRL MENA AMERICAN BIOCHE AME17 AMERICAN BIOCHEM AME17 AMERICAN BIOCHEMICAL & PHARMAS LTD AME17 AMGEN LTD AMG01 AMGEN LTD AMG01 A.M.O. UK LTD AMO02 ANGLIAN PHARMA SALES & MARKETING LT ANG03 APOLLO DISTRIBUTION SOLUTIONS APO05 AREA PHARMACEUTICAL STORES TAY02 AREA Q A LABORATORY AREA AREA QUALITY ASSURANCE SERVICES AREAQ AROMATHERAPY DIRECT LTD ARO03 ARX LIMITED ARX01 ASSOCIATED HOSPITAL SUPPLIES ASS05 ASTELLAS PHARMA LTD AST02 ASTRA ZENECA AZENE ASTRA ZENECA UK LTD ASTRA AUDEN McKENZIE (PHARMA DIVISION)LTD AUD AVENTIS PASTEUR MSD LTD AVE02 AYRTON SAUNDERS LTD AYR BANNER BUSINESS BAN01 BARD LTD BARD BAUSCH & LOMB SURGICAL (UK) LTD BAU02 BAXA LIMITED BAX06 BAXTER BIOSCIENCE BAX02 BAXTER HEALTHCARE LTD BAX01 BAXTER HEALTHCARE LTD (NEWBURY) BAX04 Baxter Healthcare Thetford BAX03 BAYER PLC DRUGS BAY01 B BRAUN MEDICAL LTD BRA01 B C M SPECIALS BCM01 BEATSON PHARMACY DISPENSARY 816 B816 BECKMAN INSTRUMENTS (UK) LTD BEC01 BIGNELL SURGICAL INST LTD BIG BIO DIAGNOSTICS BIO01 BIOGUARD Ltd BIOG BIOHIT LTD BIO13 BIO MEDICAL SERVICES LTD BIOM BIOMET LTD BIO17 BIOPHARM UK LTD BIO32 BIOSURGICAL RESEARCH UNIT BIOS BIOTEST UK BIO11 BIOVITRUM AV (PUBL) BIO74 BIRPHARM LTD BRI03 BOC EQUIPMENT DEPT BOC04 BOC LIMITED BOC02 BOC LTD NATIONAL ACC CENTRE BOC01 B O C SPECIAL GASES BOC03 BOEHRINGER INGELHEIM LIMITED BOE01 BPL (BIO PRODUCTS LABORATORY) BPL01 BRACCO E-Z01 BRACCO UK LTD BRA10 BRAY HEALTH + LEISURE LTD BRA09 BRISTOL MYERS SQUIBB BRI02 BRISTOL MYERS SQUIBB SERV. CNT BRI04 BRITANNIA PHARMACEUTICALS LTD BRI05 BRITISH TELECOMMUNICATIONS SHOP BRI92 BRITISH TELOCOMMUNICATIONS SHOP BRI92 B + S DURBIN LTD DUR02 BUNZL HEALTHCARE HOS09 BUPA HOME HEALTHCARE CLI06 CALEA UK LTD CAL15 CALEDONIAN MEDICAL SUPPLIES CAL32 CAMBRIDGE LABORATORIES LTD CAM01 CAREOLOGY LIMITED CAR01 CARTER WALLACE CART CASEN-FLEET CFL01 CASTLECARE COSMETICS CAS19 CEGEDIM RX CEG02 CELFIX LABELS CEL02 CELGENE LTD CEL10 CENTRAL HOMECARE LTD CEN46 CENTRAPHARM CEN18 CHAPTER LIMITED CHA13 CHARLES TENNANT + COMPANY LTD TEN01 CHASCO CHA06 CHAUVIN PHARMACEUTICALS LTD CHA07 CHEMIX CHE02 CHEMPRINT & PACKAGING CHE11 CIVAS PHARMACY CIVAS CLEMENT CLARKE INTERNATIONAL CLE01 CLINIGEN HEALTHCARE LTD CLI36 CLINIGEN HEALTHCARE LTD CLING CLINIMED LTD CLINI CLINIPAK LTD CLI05 CLINOVIA CLIN2 CLINOVIA LTD CLI06 COLOPLAST LTD COL04 COMMUNITY INFUSION COMI CONVATEC LTD CON01 CORINTH JPM SERVICES LTD COR18 COVIDIEN (UK) COMMERCIAL LTD TYC01 COVIDIEN (UK) COMMERCIAL LTD TYC01 COX PHARMACEUTICALS COX CRANLEA & COMPANY CRA03 CRAVENMOUNT LTD CRA32 CRAWFORD PHARMACEUTICALS CRA04 CREO PHARMA LIMITED CRE02 CREST MEDICAL LTD CRE27 CROSSHOUSE HOSPITAL CRO01 CRYOLIFE EUROPA LTD CRY05 CRYOSERVICE LTD CRY01 CSL BEHRING UK Ltd CSL05 CTS DENTAL SUPPLIES CTS01 CUSTOM CHEMICALS CUST CUTHBERTSON & LAIRD GROUP CUTH DADE BEHRING LTD DAD01 DATEX OHMEDA LIMITED DAT04 DATEX OHMEDA LTD DATEX DENTAL DIRECTORY DEN20 DHL EXPRESS UK DHL02 DHP (QUAESTUS) DHP02 DIAGENICS LTD DIA17 DIAGMED LTD DIA12 DISPENSARY GARTNAVEL (652) LS652 DISPENSARY GARTNAVEL ROYAL (652) LS652 DISTINCTIVE MEDICAL CARE DIS06 DISTINCTIVE MEDICAL PRODUCTS NICHO DISTRIPHAR UK DIS07 DLT PODIATRY DLT01 DONATION ENVELOPES LTD DON05 DOOP Services LTD (PHS Group) DOOP1 DOWELHURST LTD DOW06 DOWNS SURGICAL LTD DOWNS DR.REDDY'S LABS UK LTD BIOM DTR Medical Limited DTR01 Dumfries & Galloway Royal Inf Pharm DGPHA EASTBOURNE DGH PHARMACEUTICALS EAS11 E C DeWITT & CO LIMITED DEW01 EDEN MEDICAL EDE01 EDWARDS LIFESCIENCES EDW01 EISAI LTD EIS01 E MERCK + LIPHA MER05 ENVAIR UK LTD ENV05 ENVOPAK GROUP LTD ENV04 ERIC JAEGER LTD JAE02 ESSENTIAL NUTRITION LIMITED ESS07 EUMEDICA EUM01 EUMEDICA S.A. EUM EURODEP EUR01 EUROMED LTD EUR18 EUSA PHARMA EUS01 EVOLUTION HOMECARE SERVICES LTD EVO03 EXCHANGE SUPPLIES LTD EXC03 E-Z-EM LTD E-Z01 FAMILY PLANNING SALES LTD FAM FAST AID PRODUCTS LTD FAS03 FAULDING PHARMACEUTICALS FAUL FERRING PHARMACEUTICALS LTD FER01 FISHER & PAYKEL HEALTHCARE FIS04 FOCUS PHARMACEUTICAL LTD FOC10 FOCUS PHARMACEUTICAL LTD FOCCD FOOD PARTNERS LIMITED FOO08 FREEMANS CHEMISTS FRE07 FRESENIUS KABI LIMITED FRE01 FRESENIUS MEDICAL CARE (UK) LT FRE02 FRESENIUS MEDICAL CARE (UK) LTD FRE08 GALDERMA UK LTD GAL08 GAMBRO LTD GAM02 GAS CONTROL EQUIPMENT LTD GAS04 GB (UK) LTD HEALTHCARE GBU01 G DAY SURGERY ANAESTHETIC GDASA G DAY SURGERY LOTIONS GDASL G DAY SURGERY ORAL GDASO GE HEALTHCARE AME12 GE HEALTHCARE CLINICAL SYSTEMS (UK) DAT04 GEISTLICH SON LTD PHARM GEI01 GENTA MEDICAL GEN05 GENUS PHARMACEU GEN21 GENUS PHARMACEUTICALS GEN21 GENUS PHARMACEUTICALS GENUS GENZYME GEN27 GENZYME BIOSURGERY GEN22 GENZYME THERAPEUTICS LTD GEN22 GEORGE BOYD CO LTD GEORG GGH INFUSIONS WARD BOX ASSEMBLY GGWI GILEAD SCIENCES LTD GIL07 GLASGOW HOMEOPATHIC HOSPITAL 370 G370 GLASGOW ROYAL INFIRMARY GLAR GLASGOW WESTERN INFIRMARY GLAW1 GLASGOW WESTERN INFIRMARY GLAW2 GLAXO SMITHKILINE GLA01 GLAXO WELLCOME UK LTD GLA15 GOLDEN JUBILEE NATIONAL HOSPITAL GOL03 GOLDEN JUBILEE NATIONAL HOSPITAL GOLDE Goldshield GOL10 GOLDSHIELD PHARMACEUTICALS GOL10 GOLDSHIELD PHARMACEUTICALS GOLCD GOLDSHIELD PHARMACEUTICALS LTD GOL10 GRAHAM GROUP PLC GRA05 GRASEBY MEDICAL GRASE GRI ASEPTIC UNIT 808 R808 GSK HARLOW CLINICAL TRIAL SUPPLIES GLA02 GUARBET GUE01 GUYS & ST THOMAS PRODUCTION UNIT GUY02 HAIRMYRES HOSPITAL HAI02 HAIRMYRES HOSPITAL HAIR HAMELN PHARMACEUTICALS HAM02 HAMELN PHARMACEUTICALS HAM02 HAMELN PHARMACEUTICALS HAMCD HAMELN PHARMACEUTICALS LIMITED PHO02 HAMPTON LTD HAM38 HAYMAN LTD HAY01 HC SLINGSBY PLC SLI01 HEALTHCARE AT HOME LTD., HEA26 HEALTHCARE LOGISTICS HEALF HEALTHCARE LOGISTICS HEALG HEALTHCARE LOGISTICS HEALP HEALTHCARE PRODUCT SERVICES HEAL2 HEALTH PROTECTION AGENCY HPA HELAPET LTD HEL04 HEMOCUE LTD HEMO HENLEYS MEDICAL SUPPLIES LTD HEN01 HENRY SCHEIN SCH01 HENRY SCHEIN PROCARE SCH03 H M + S (GLASGOW) LIMITED HMS09 HOLLISTER LIMITED HOL02 HOSPIRA ASEPTIC SERVICES LTD INT25 HOSPIRA (CHEMO DEPT) HOS25 HOSPIRA UK LIMITED HOS22 HOSPIRA UK LIMITED HOS22 HOSPITAL INNOVATIONS HOS31 HOSPITAL MANAGEMENT & SUPPLIES HOSP HUDDERSFIELD PRODUCTION UNIT HUD HUDDERSFIELD ROYAL INFIRMARY HUD01 HUDDERSFIELD ROYAL INFIRMARY HUDD HUNTLEIGH HEALTHCARE HUN ICN PHARMACEUTICALS LTD ICN01 IDIS WORLD MEDICINES IDI01 IDIS WORLD MEDICINES IDI01 IDIS WORLD MEDICINES GGC001 IDI01 INDUSTRIAL PHARMA SERVICES IND03 INFAI UK LIMITED INF10 INO THERAPEUTICS INO01 INSIGHT BIOTECH LTD INS01 INSIGHT BIOTECH LTD INS01 INSIGHT DIRECT (UK) LTD INS02 INSPIRATION HEALTHCARE LIMITED INS45 INTRA-TECH HEALTHCARE LIMITED INT INVERCLYDE BIOLOGICALS INV02 INVERNESS MEDICAL UK INV88 IPSEN LTD IPS01 IPSWICH HOSPITAL IPS03 IPSWICH HOSPITAL IPS03 ITH PHARMA ITH02 itu lotions WITUL IVAX PHARMACEUTICALS IVA06 IVAX PHARMACEUTICALS IVA06 IVEX PHARMACEUTICALS LIMITED IVE01 JANSSEN CILAG LTD JAN01 JANSSEN CILAG LTD JAN01 JANSSEN CILAG LTD JANCD JANSSEN CILAG LTD JANRO JANSSEN CILAG LTD JANS2 JAVELIN PHARMACEUTICALS UK LTD JAV J BRADBURY (HEALTHCARE) LTD BRA04 JHC HEALTHCRE LTD JHC02 J M LOVERIDGE PLC LOV01 JOHN BELL + CROYDEN BEL03 JOHNSEN & JORGENSEN JOH04 JOHNSON & JOHNSON LTD JOH02 JOHNSTON & JOHNSTON MEDICAL LTD JOH99 JUBB UK LTD JUB01 KARL STORZ KAR06 KENT PHARMACEUTICALS KEN13 KENT PHARMACEUTICALS KEN13 KENT PHARMACEUTICALS KENT KESTREL OPTHALMICS KES04 KEY CATERING PLC KEY03 K/L PHARMACEUTICAL LTD PHA01 KORA HEALTHCARE KOR02 LABCAIRE SYSTEMS LTD LAB06 LABORATORIES BIOCEDEX LAB27 LAERDAL MEDICAL LTD LAERD LAMBERT HEALTHCARE LAM06 LAMBERT HEALTHCARE LAM06 LANCASHIRE TEACHING HOSPITALS NHS LAN24 LANCASHIRE TEACHING HOSPITALS NHS T LAN24 LAWTONS LTD LAW02 L & B CONTAINERS CON04 LEO LABORATORIES LIMITED LEO01 LIDCO LTD LID02 LIDCO LTD LID02 LIFESYSTEMS LIMITED LIF06 LILLY INDUSTRIES LTD LIL01 LILLY INDUSTRIES LTD LIL01 Linc Healthcare Logistics Ltd LIN02 LUNDBECK LIMITED LUN01 LUTON & DUNSTABLE HOSPITAL LUTON MACKAY + INGLIS LTD MAC04 MACO PHARMA at TPS MAC16 MACO PHARMA at TPS MAC16 MANDEVILLE MEDICINES MAN20 MANDEVILLE MEDICINES MAN20 M & A PHARMACHEM LTD PHA18 M & A PHARMACHEM LTD PHA18 MARTINDALE PHARMACEUTICALS MAR08 MARTINDALE PHARMACEUTICALS MARCD MARTINDALE PHARMACEUTICALS UM MARUM MASTA MED49 MASTA UNLICENCED MEDICINES MASUM MASTERS PHARMA LTD MAS24 MATES HEALTHCARE MATES MAWDSLEY BROOKS MAW02 MAWDSLEY PRE WHOLESALE MAW04 MAWDSLEYS MAW41 MAWDSLEYS PRE WHOLESALE MAW40 MAWDSLEYS PRE WHOLESALE MAWRO MAWDSLEYS PRE WHOLESALE MAWRO MAWDSLEYS UNLICENCED MAW01 MAWDSLEYS UNLICENCED MAW01 MAYNE PHARMA PTY LTD UM MAY22 MAYNE PHARMA PTY LTD
Load more

Recommended publications
  • Chief Executive Officer Graham Baker
    OVERVIEW OUR BUSINESS OPERATIONAL FINANCIAL RISK GOVERNANCE ACCOUNTS 48 & MARKETPLACE REVIEW REVIEW OUR BOARD OF DIRECTORS ROBERTO QUARTA (67) OLIVIER BOHUON (58) GRAHAM BAKER (48) CHAIRMAN CHIEF EXECUTIVE OFFICER CHIEF FINANCIAL OFFICER Joined the Board in December 2013 and Joined the Board and was appointed Chief -RLQLQJWKH%RDUGDV&KLHI)LQDQFLDO2I²FHULQ appointed Chairman following election by ([HFXWLYH2I²FHULQ$SULO+HUHVLJQHGDV March 2017. shareholders at the April 2014 Annual General a Member of the Nomination & Governance Meeting. He was also appointed Chairman of &RPPLWWHHRQ)HEUXDU\ CAREER AND EXPERIENCE the Nomination & Governance Committee and Graham holds an MA degree in Economics from a Member of the Remuneration Committee on CAREER AND EXPERIENCE Cambridge University and qualified as a Chartered that day. Olivier holds a doctorate in Pharmacy from the Accountant and Chartered Tax Advisor with Arthur University of Paris and an MBA from HEC, Paris. Andersen. In 1995, he joined AstraZeneca PLC where CAREER AND EXPERIENCE He started his career in Morocco with Roussel Uclaf he worked for 20 years, holding multiple senior roles, Roberto is a graduate and a former Trustee of the S.A. and then, with the same company, held a number including Vice President, Finance, International (2013- College of the Holy Cross, Worcester (MA), US. of positions in the Middle East with increasing levels of 2015) with responsibility for all emerging markets, He started his career as a manager trainee at David responsibility. He joined Abbott in Chicago as head of Vice President, Global Financial Services (2011-2013) Gessner Ltd, before moving on to Worcester Controls their anti-infective franchise with Abbott International and Vice President Finance & Chief Financial Officer, Corporation and then BTR plc, where he was a before becoming Pharmaceutical General Manager North America (2008-10).
    [Show full text]
  • Register of GDP Sites 2019
    Register of GDP Sites 2019 Updated 16 August 2019 There are other sites authorised for wholesale dealing of veterinary medicinal products which do not appear on this register. These sites wholesale deal in both human and veterinary medicinal products and can be found on the MHRA section of GOV.UK: https://www.gov.uk/government/publications/human-and-vetinary-medicines- register-of-licensed-wholesale-distribution-sites-december-2014 Register of Authorised Wholesale Dealer Sites Authorisation Holder: WDA33618 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0415 ABBEYVET LLP 310 CHESTER ROAD, HARTFORD, NORTHWICH, CHESHIRE, CW8 2AB SITE ID: S0010 ABBEYVET LLP SHERBURN ENTERPRISE PARK, SHERBURN IN ELMET, LEEDS, WEST YORKSHIRE, LS25 6NB Authorisation Holder: WDA8599 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN SITE ID: S0015 AGRIHEALTH (N.I.) LIMITED 9 SILVERWOOD INDUSTRIAL AREA, SILVERWOOD ROAD, LURGAN, CRAIGAVON, COUNTY ARMAGH, BT66 6LN Authorisation Holder: WDA5097 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0456 ALBAVET LIMITED BUSINESS INCUBATOR OFFICE 21, MYREGORMIE PLACE, MITCHELSTON INDUSTRIAL ESTATE, KIRKCALDY, FIFE, KY1 3NA SITE ID: S0525 CVS GROUP PLC CVS HOUSE, OWEN ROAD, DISS, NORFOLK, IP22 4ER Authorisation Holder: WDA5030 ALBERT E JAMES & SON LIMITED BARROW MILL BARROW STREET, BARROW GURNEY, BRISTOL, BS48 3RU SITE ID: S0303 ALBERT E JAMES &
    [Show full text]
  • United States Securities and Exchange Commission Form 10-K Shire Pharmaceuticals Group
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ፤ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1999 អ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) N.A. East Anton, Andover, Hampshire SP10 5RG England (Address of principal executive offices) (Zip Code) 44 1264 333455 (Registrant's telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depository Shares, each representing Nasdaq National Market 3 Ordinary Shares, 5 pence nominal value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ፤ No អ Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant's knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • Listing of Global Companies with Ongoing Government Activity
    COMPANY LINE OF BUSINESS TICKER A & A BIOTECHNOLOGY S C ADAM BURKIEWICZ MIKOLAJ BURKIEWICZ PHARMACEUTICAL PREPARATIONS A & A GLOBAL INDUSTRIES, INC. AUTOMATIC VENDING MACHINES, NSK A & J ENTERPRISES PHARMACEUTICAL PREPARATIONS A & S INTERNATIONAL 2000 S.R.L. PHARMACEUTICAL PREPARATIONS A & S PHARMACEUTICAL CORP. PHARMACEUTICAL PREPARATIONS A & T MARKETING INC. COMPUTER INTEGRATED SYSTEMS DESIGN, NSK A & T SYSTEMS, INC. TELEPHONE COMMUNICATION, EXCEPT RADIO A & Z PHARMACEUTICAL INC. PHARMACEUTICAL PREPARATIONS A A INTERNATIONAL PHARMACEUTICAL PREPARATIONS A AND V, INC. BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC A AROGYA HARBALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A B ENTERPRISES PHARMACEUTICAL PREPARATIONS A B I HERBAL PRODUCTS MEDICINALS AND BOTANICALS, NSK A B S REMEDIES PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A BEAT FOR YOUR FEET, INC. COIN-OPERATED LAUNDRIES AND CLEANING, NSK A BUCKHEAD BUS COMPANY LOCAL PASSENGER TRANSPORTATION, NEC A C C VIEIRA PROTESE ME MEDICINALS AND BOTANICALS, NSK A C CONSULTING PHARMACEUTICAL PREPARATIONS A C E DIAGNOSTICS & BIOTECH LIMITED PHARMACEUTICAL PREPARATIONS A C E PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A C PHARMACEUTICALS PRIVATE LIMITED PHARMACEUTICAL PREPARATIONS A CUT ABOVE LANDSCAPE LAWN AND GARDEN SERVICES A D C O MARKETING INC NONDURABLE GOODS, NEC, NSK A G HERBALS PRIVATE LIMITED MEDICINALS AND BOTANICALS, NSK A G PHARMACEUTICALS PHARMACEUTICAL PREPARATIONS A H C PHARMACAL, INC PHARMACEUTICAL PREPARATIONS A H SYSTEMS INC INSTRUMENTS TO MEASURE ELECTRICITY A HOUSE OF AYURVEDIC
    [Show full text]
  • CRR 446/2002 a Study of the Provision of Health and Safety Information in the Annual Reports of the Top UK Companies
    HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Prepared by System Concepts Ltd for the Health and Safety Executive CONTRACT RESEARCH REPORT 446/2002 HSE Health & Safety Executive A study of the provision of health and safety information in the annual reports of the top UK companies Laura Peebles, Ansgar Kupper and Tanya Heasman System Concepts Ltd 2 Savoy Court Strand London WC2R 0EZ This report details the findings of a research project to investigate the quality and quantity of health and safety information found in the annual reports of the top UK companies. At present, publicly listed companies are not legally required to include health and safety matters in their annual reports. The current Health and Safety Commission (HSC) Strategy Statement, however, contains an action point which focuses on public reporting of health and safety issues by larger companies. The aim is to promote the reporting of health and safety information in company annual reports and to provide guidance that would allow reporting of such information to a common standard. To assist the HSC with this strategy, System Concepts were commissioned by the Health and Safety Executive (HSE) to undertake an investigation of the provision of health and safety information in company annual reports. The study comprised a series of steps. The main objectives of the study were: i) To determine the current level of reporting of health and safety issues in annual reports of the top UK companies ii) To determine the quality of health and safety information reported.
    [Show full text]
  • Rape Research
    Rape Research After scene 2, in Paulson‘s Tavern, Tara is left behind whilst it empties out. This is the perfect setting for Danni to tranquilise her with a date rape drug. This is quite a strong subject, and I felt like the whole group should put more research and get a greater understanding, so we know how to deal with the situation and portray it through our performance. Personally, I have never known anyone who has experienced this situation before, so to ensure that I would create a believable performance and reaction, I needed to get a greater understanding and look at interviews, dramas and information about date rape and the affect it has on people‘s lives. BBC Health – Rohypnol http://www.bbc.co.uk/health/physical_health/conditions/rohypnol.shtml What is Rohypnol? Rohypnol is the brand name of a medicine called flunitrazepam, and is one of the benzodiazepine class of sedative or tranquilizer drugs, of which ‗Valium‘ or diazepam is perhaps the best known. Rohypnol or flunitrazepam is 10 times more potent than diazepam. In the UK the drug is no longer used in the NHS but may be available on private prescription for those who need it (although it‘s generally felt that there are better alternatives). Its legal status in the UK is a class C drug, which means that it‘s illegal to possess flunitrazepam without a prescription. It‘s not legally available in the US, but as it is still made in some countries an illegal trade continues. Rohypnol rose to prominence as the date rape drug because it was colourless, odourless, tasteless and easily dissolved - ideal for spiking drinks undetected - and causes sedation or euphoria in approximately 20 to 30 minutes.
    [Show full text]
  • Cold Chain Distribution Conference and Exhibition Enhance Temperature Management for an Efficient Supply Chain
    SMi PRESENTS THE 9TH ANNUAL COLD CHAIN DISTRIBUTION CONFERENCE AND EXHIBITION ENHANCE TEMPERATURE MANAGEMENT FOR AN EFFICIENT SUPPLY CHAIN 2ND - 3RD DECEMBER 2014 | MARRIOTT REGENTS PARK, LONDON UK Sponsorship Manual www.coldchain-distribution.com “ A very well organised event. Professional team and well executed” Cold Chain Delegate 2013 9th annual Cold Chain Distribution Conference and Exhibition Drawing on 8 years of working within the Cold Chain Logistics industry, the SMi Group are delighted to announce their 9th annual Cold Chain Distribution Conference and Exhibition. Join this event and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on the key issues surrounding the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. Benefits of Attending: ● Benchmark and reflect on the implementation of the GDP directive with case studies from IATA, AbbVie and the Dutch Health Care Inspectorate ● Enhance your understanding of the challenges of transport qualification for temperature sensitive pharmaceutical products with a round table discussion led by Tony Wright, Managing Director, Exelsius Cold Chain Management and an opening address from Alan Dorling, Global Head – Pharmaceutical & Life Sciences, IAG Cargo ● Strengthen your supply chain through management and efficiency insights from Merck Serono and Genzyme ● In addition, Cold Chain Distribution
    [Show full text]
  • 1999 Annual Report and Form 20-F CONTENTS
    1999 Annual Report and Form 20-F CONTENTS Key Achievements in 1999 1 Financial Highlights 2 Shareholder Highlights 5 Chairman’s Statement 6 Chief Executive’s Review 7 Operational Review 8 Safety, Health and Environment 32 In April 1999, Astra AB and Zeneca Group PLC People and Community 34 merged to form AstraZeneca, one of the world’s Financial Review 35 leading pharmaceutical and agrochemical Board of Directors and Officers companies, which provides innovative, effective of the Company 48 products to improve health, nutrition and quality Directors’ Report 49 of life worldwide. The company is research and Financial Statements 55 technology intensive, with extensive international Financial statements and notes development and marketing skills. Its healthcare relating to the financial statements 55 business is strategically focused on seven major Principal subsidiaries, joint ventures therapeutic areas: gastrointestinal, oncology, pain and associates 118 control and anaesthesia, cardiovascular, central Additional information for US investors 120 nervous system, respiratory and infection. Zeneca Group Financial Record 129 Agrochemicals provides crop protection products Shareholder Information 131 designed to improve crop yields and food quality. Exchange rates 138 Definitions 139 Glossary of Terms 140 Cross Reference to Form 20-F IBC Cautionary statement regarding forward-looking statements In order to utilise the ‘Safe Harbor’ provisions of the United States Private Securities Litigation Reform Act of 1995, AstraZeneca is providing the following cautionary statement. This Annual Report and Form 20-F 1999 contains forward-looking statements with respect to the financial condition, results of operations and businesses of AstraZeneca. By their nature, forward-looking statements and forecasts involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future.
    [Show full text]
  • SHIRE PHARMACEUTICALS GROUP PLC (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 0-29630 SHIRE PHARMACEUTICALS GROUP PLC (Exact name of registrant as specified in its charter) England and Wales 98-0359573 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Hampshire International Business Park, Chineham, +44 1256 894 000 Basingstoke, Hampshire, England, RG24 8EP (Registrant’s telephone number, including area code) (Address of principal executive offices and zip code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Name of exchange on which registered American Depositary Shares, each representing 3 NASDAQ National Market Ordinary Shares 5 pence par value per share Securities registered pursuant to Section 12(g) of the Act: None (Title of class) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [ ] Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference to Part III of this Form 10-K or any amendment to this Form 10-K.
    [Show full text]
  • An Emerging National Resource for Clinical Research and Your Healthcare Partner in Personalized Medicine Innovation
    An Exclusive Membership Look into Colorado To visualize improving the world around us Fisher Scientifi c, part of Thermo Fisher Scientifi c, the world leader in serving science, is pleased to have the opportunity to partner with the Colorado BioScience Association and act as primary supplier of laboratory products, safety supplies, equipment, chemicals, reagents and a host of services. Fisher Scientifi c understands today’s challenging environment and has capabilities that align with CBSA’s strategic goals going beyond just providing products to o ering Colorado BioScience Association members access to customized programs to fi t their specifi c needs from start-up to scale-up. 1.800.766.7000 • Fax: 1.800.926.1166 • www.fi shersci.com 2 BIOSCIENCECOLORADO 2014-2015 Litho in U.S.A. 13_0280 JJ/KJ COLOR ADO 2014-2015 Drawing People & Data Together to Benefit Human Health 10 22 26 14 6 CONTENTS 06 Mobile Health in Colorado: Where “Big Data” Sparks Big Ideas 10 Biodesix Harnesses Machine Learning and Analytics to Tackle Multivariate Diagnostics 14 Bioscience in Colorado Continues to Shine with U.S. Senator Michael Bennet 16 Color ado Life Science Assets: A Sophisticated Repertoire of Clinical-Stage Therapeutic, Device and Diagnostic Products 22 Webb-Waring Biomedical Research Program 26 F ound in Translation: Rocky Mountain Lions Eye Institute Translational Research Programs Focus on Innovative Treatment of Eye Diseases 30 Connecting the Dots: Tech Transfer Offices Connect Research and Marketplace to Stimulate the State's Economy 33 Colorado by the Numbers: Financing and Acquisitions 36 Grant Programs: Innovation Engines 48 Colorado Bioscience Industry Directory 2014-2015 BIOSCIENCECOLORADO 3 We Know Workforce elcome to the Colorado BioScience Association’s eleventh anniversary edition of Bioscience Colorado.
    [Show full text]
  • Astrazeneca Notice of AGM 2007
    NOTICE OF ANNUALAND SUMMARY GENERAL MEETINGFINANCIAL STATEMENT 2007 AND SHAREHOLDERS’ cIRCULAR WorldReginfo - 94cdbe6b-e6ef-4290-869e-95f1d4a336fd WorldReginfo - 94cdbe6b-e6ef-4290-869e-95f1d4a336fd LETTER FROM THE CHAIRMAN 1 LETTER FROM THE CHAIRMAN THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE AttENTION. IF YOU ARE or incurring because of the Political Parties, IN ANY DOUBT ABOUT ITS CONTENTS OR WHAT ACTION YOU SHOULD TAKE, YOU SHOULD Elections and Referendums Act 2000 in the CONSULT YOUR INDEPENDENT FINANCIAL ADVISER. IF YOU HAVE SOLD OR TRANSFERRED ALL UK (“the Act”). OF YOUR ASTRAZENECA ORDINARY SHARES YOU SHOULD SEND THIS DOCUMENT AND THE ACCOMPANYING DOCUMENTS TO THE PURCHASER OR TRANSFEREE OR TO THE STOCKBROKER, The Company has no intention of changing its BANK OR OTHER AGENT THROUGH WHOM THE SALE OR TRANSFER WAS EFFECTED FOR current practice of not making donations to TRANSMISSION TO THE PURCHASER OR TRANSFEREE. political parties in the EU and it will not do so without the specific endorsement of its shareholders. However, the Act defines DEAR SHAREHOLDER Senior Independent Director. Sir Peter was ‘political organisation’ widely so as to include, On behalf of the Board of AstraZeneca PLC, first appointed to the Board in January 1995. amongst other things, an organisation that I enclose various documents concerning your carries on activities that are capable of being shareholding in the Company. These are: On behalf of the whole Board, I would like reasonably regarded as intended to influence to express our gratitude to Erna and Sir public support for a political party in any EU 1 A Shareholders’ Circular incorporating Peter for their considerable contribution to member state or to influence voters in relation the formal Notice of the Annual General AstraZeneca’s success and wish them both to any referendum in any EU member state.
    [Show full text]
  • FTSE 100 Constituent History Updated
    FTSE 100 Constituent Changes Date Added Deleted Notes 19-Jan-84 CJ Rothschild Eagle Star 02-Apr-84 Lonrho Magnet Sthrns. 02-Jul-84 Reuters Edinburgh Inv. Trust 02-Jul-84 Woolworths Barrat Development 19-Jul-84 Enterprise Oil Bowater Corporation 01-Oct-84 Willis Faber Wimpey (George) 01-Oct-84 Granada Group Scottish & Newcastle 01-Oct-84 Dowty Group MFI Furniture 04-Dec-84 Brit. Telecom Matthey Johnson 02-Jan-85 Dee Corporation Dowty Group 02-Jan-85 Argyll Group Berisford (S.& W.) 02-Jan-85 MFI Furniture RMC Group 02-Jan-85 Dixons Group Dalgety 01-Feb-85 Jaguar Hambro Life 01-Apr-85 Guinness (A) Enterprise Oil 01-Apr-85 Smiths Inds. House of Fraser 01-Apr-85 Ranks Hovis McD. MFI Furniture 01-Jul-85 Abbey Life Ranks Hovis McD. 01-Jul-85 Debenhams I.C. Gas 06-Aug-85 Bnk. Scotland Debenhams 01-Oct-85 Habitat Mothercare Lonrho 02-Jan-86 Scottish & Newcastle Rothschild (J) 08-Jan-86 Storehouse Habitat Mothercare 08-Jan-86 Lonrho B.H.S. 01-Apr-86 Wellcome EXCO International 01-Apr-86 Coats Viyella Sun Life Assurance 01-Apr-86 Lucas Harrisons & Crosfield 01-Apr-86 Cookson Group Ultramar 21-Apr-86 Ranks Hovis McD. Imperial Group 22-Apr-86 RMC Group Distillers 01-Jul-86 British Printing & Comms. Corp Abbey Life 01-Jul-86 Burmah Oil Bank of Scotland 01-Jul-86 Saatchi & S. Ferranti International 01-Oct-86 Bunzl Brit. & Commonwealth 01-Oct-86 Amstrad BICC 01-Oct-86 Unigate Smiths Industries 09-Dec-86 British Gas Northern Foods 02-Jan-87 Hillsdown Holdings Argyll Group 02-Jan-87 I.C.
    [Show full text]